Liminatus Pharma, Inc.
LIMN·NasdaqCM·Healthcare
3.4500−0.3100 (−8.24%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close3.7600
Open3.7000
Day range3.40003.8200
52-week range3.2900141.5000
Off day high−9.69%
Off 52-week high−97.56%
Volume28.75K
Avg. volume (3M)451.89K
Market cap4.63M
EPS (TTM)-25.54
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.75
Shares outstanding1.34M
Short interest4.12% of float
Earnings date—
Analyst target—
Profit margin0.00%
Against its peers
Compare in full ›| LIMN | PCSA | AIM | BCAB | APVO | BYSI | |
|---|---|---|---|---|---|---|
| Market cap | 4.63M | 5.31M | 7.08M | 2.08M | 3.32M | 25.31M |
| P/E (TTM) | — | — | — | — | 0.0 | — |
| Forward P/E | — | -0.5 | -0.5 | -0.9 | -0.2 | -1.3 |
| Price/book | 12.8 | -16.7 | 0.7 | -0.1 | 0.4 | -0.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −94.89% | −80.81% | −93.00% | −96.88% | −93.74% | −62.44% |
| Today | −8.24% | +25.00% | −1.44% | −16.67% | +2.79% | +1.63% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All LIMN news ›Liminatus Pharma Regains Nasdaq Compliance After Reverse Split
Liminatus Pharma ( (LIMN) ) has shared an announcement. On January 15, 2026, Liminatus Pharma, Inc. was notified by Nasdaq that its shares had closed below $1.00 for 30 consecutive business days, placing the company out of compliance with…
From articles in the 4Search news index.
In the news
2mentions in 30 days
2with it in the headline
Mixedsentiment
Mentioned with
People in the coverage
Most coverage from
-
seekingalpha.com1
-
theglobeandmail.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.